Cleveland Clinic seeks treatment for Alzheimer’s

Editor’s note: While Robin Leach is on vacation, Dr. Jeff Cummings, head of the Cleveland Clinic Lou Ruvo Center for Brain Health, will be the guest column today. He will give us an update on the center’s work in the battle against Alzheimer’s and other brain degenerative diseases.

……

Currently, there is a gray tsunami lurking on the horizon, posing an eminent threat socially and economically. The tsunami will make landfall by 2030, when it’s estimated that nearly 75 million people worldwide will have Alzheimer’s disease (AD), with the cost of caring for these individuals reaching $1 trillion.

This is a financial burden that we cannot bear, which is why the Obama Administration, as well as several member nations attending the 2013 G8 Dementia Summit, established a goal of developing a meaningful treatment for AD by 2025. Since then, researchers worldwide have been racing to develop a cure or treatment.

Time is ticking and in an effort to better understand where we are at in the AD drug development process, I, along with fellow researchers at Cleveland Clinic Lou Ruvo Center for Brain Health as well as colleagues from Touro University and Global Alzheimer’s Platform, have begun a yearly analysis of the AD drug pipeline.

We recently concluded our second assessment and published results in the paper called “Alzheimer’s Disease Drug Development: Pipeline 2017” in the Journal of Alzheimer’s & Dementia: Transitional Research & Clinical Trials Interventions.

The paper sheds light on the immediate challenges of AD drug development and the urgent need to increase the number of agents entering the pipeline to accelerate the drug-testing process.

Using a comprehensive analysis of ClinicalTrials.Gov, where all clinical trials are registered (by law), we examined all clinical trials from 2016 to 2017 and found that the number of agents in the pipeline is small — 105. In addition, compared to the 2016 pipeline, there are only eight new agents in Phase 1, illustrating a desperately slow period in AD drug development.

To meet our 2025 goal, an agent must currently be in the second of three phases of drug development. The third phase leads to Food and Drug Administration review and possible approval. Given the state of the pipeline, the approval of one or two drugs is plausible, but the goal of developing an effective treatment or prevention for many of the patients with AD is in jeopardy.

In addition to high drug failure rates, we also uncovered obstacles that inhibit drug development, which include slow clinical trial recruitment and drug testing as well as a lack of sufficient funding. Currently, the National Institute of Health spends an annual $6 billion on cancer research, more than $4 billion in heart disease research, $3 billion on HIV/AIDS research and less than $2 billion on AD research.

Cleveland Clinic believes we must address these inhibiting factors in order to increase the success rate and accelerate the development of new therapies. Our paper serves as a call to action and, as a leader in research, we are ready to help orchestrate the changes needed to enhance the drug-testing process.

While there are countless ways to improve the AD pipeline, we have identified several areas we believe can significantly advance drug development. Repurposing drugs already approved by the FDA to treat other diseases can help speed up the drug development timeline and increasing investments in basic research can aid in identifying new therapies.

Slow recruitment of participants is the most expensive part of clinical trials and arguably, the greatest challenge in drug development. A national effort is needed to address this issue as a staggering 54,000 participants are needed to complete the current list of AD trials. The Global Alzheimer’s Platform — a nationwide program in which Cleveland Clinic takes a leading role — was created for this very reason. One way to expedite recruitment is to utilize biomarkers such as brain imaging to identify qualified clinical trial candidates.

The need is great, the challenges are many, the rewards are high — this is the status of the AD pipeline. As a scientist, I remain hopeful that an effective treatment is in sight because there has never been a greater, more coordinated effort to develop a cure. Amazing work takes place daily at the Lou Ruvo Center for Brain Health and we are at the forefront of ground-breaking research that will impact the world.

ad-high_impact_4
Entertainment
Nevada Ballet Theatre rehearses for "Dracula" at The Smith Center
Nevada Ballet Theatre rehearses for "Dracula" at The Smith Center (Janna Karel/ Las Vegas Review-Journal)
Downtown Summerlin hosts its annual Festival of Arts
People crowd to Downtown Summerlin for the 23rd annual Summerlin Festival of Arts in Las Vegas, Sunday, Oct. 14, 2018. (Caroline Brehman/Las Vegas Review-Journal)
Bellagio, MGM Resorts International’s luxury hotel turns 20
The more than 3,000-room Bellagio hotel is situated on the site of the former Dunes Hotel. The Dunes was imploded in 1993, and construction of the Bellagio started in 1996. It cost $1.6 billion to build, making it the most expensive hotel in the world at the time. The Bellagio was former Wynn Resorts Ltd. Chairman and CEO Steve Wynn’s second major casino on the Strip after The Mirage. MGM Resorts International acquired the property from Steve Wynn in 2000. (Tara Mack/Las Vegas Review-Journal)
Recycled Art and Cute Dogs at Summerlin Festival Of Arts
Recycled Art, Cute Dogs Abound At Summerlin Festival Of Arts (Janna Karel Las Vegas Review-Journal)
Bellagio Patisserie Creates Life-size Sculpture Of 20th Anniversary Of Cirque Du Soleil Show
Bellagio Patisserie Creates Life-size Sculpture Of 20th Anniversary Of Cirque Du Soleil Show (Janna Karel/Las Vegas Review-Journal)
10 Most Iconic Moments At The Bellagio Fountains
10 Most Iconic Moments At The Bellagio Fountains (Janna Karel/Las Vegas Review-Journal)
Jason Aldean talks about the possibility of a Las Vegas residency
Country superstar Jason Aldean discusses his feelings about playing in Las Vegas and says he'd be interested in a Las Vegas residency when the time is right at the iHeart Radio Music Festival in Las Vegas on September 21, 2018.(John Katsilometes/Las Vegas Review-Journal)
Block 16 Urban Food Hall Serves Favorite Foods From Across The US
Block 16 Urban Food Hall Serves Favorite Foods From Across The US (Janna Karel Las Vegas Review-Journal)
Benny the Skating Dog could be the next Golden Knights on-ice entertainment
Benny the Skating Dog could be the next Golden Knights on-ice entertainment (Janna Karel Las Vegas Review-Journal)
Who To Watch At Life Is Beautiful
Life Is Beautiful Setup
Workers preparing Fremont street for this weekend's Life is Beautiful festival, on Wednesday, September 19, 2018. Mat Luschek/Las Vegas Review-Journal
The 46th annual Greek Food Festival will feed 25,000 people in Las Vegas
Madame Tussauds Has The Newest VR Experience On The Strip
Madame Tussauds Has The Newest VR Experience On The Strip. (Janna Karel Las Vegas Review-Journal)
Zia Records Move
Zias Records is moving from its Sahara Avenue and Arville Street location to a bigger store. (Mat Luscheck/Las Vegas Review-Journal)
Students At The International Contortion Convention In Las Vegas Learn How To Bend And Twist Their Bodies
Students At The International Contortion Convention In Las Vegas Learn How To Bend And Twist Their Bodies. (Janna Karel Las Vegas Review-Journal)
Video from Fertitta wedding Sep. 1
video from @wedstagrams of Fertitta wedding at Red Rock Resort
You Can Get Vegan Unicorn Toast In Downtown Las Vegas
You Can Get Vegan Unicorn Toast In Downtown Las Vegas (Janna Karel Las Vegas Review-Journal)
Five must-see bands at Psycho Las Vegas 2018
Five must-see bands at Psycho Las Vegas 2018
Zuma's Ice Cube Carving Is Satisfying To Watch
Zuma's Ice Cube Carving Is Satisfying To Watch (Janna Karel Las Vegas Review-Journal)
Therapy In Downtown Las Vegas Serves Cast Iron S'mores
Therapy In Downtown Las Vegas Serves Cast Iron S'mores. (Janna Karel Las Vegas Review-Journal)
TOP NEWS
News Headlines
ad-infeed_1
ads_infeed_2
Local Spotlight
Add Event
Home Front Page Footer Listing
Circular
You May Like

You May Like